GOTHENBURG, Sweden, June 9, 2016 /PRNewswire/ -- Today, Diasend takes a new innovative leap in its mission to simplify life with diabetes for both patients and health care providers by adding yet another notable cloud-to-cloud connection. In collaboration with the diabetes care business of Abbott, the global healthcare company, Diasend now introduces seamless integration using the mobile application LibreLink*, designed for the FreeStyle® Libre flash glucose monitoring system.
"It's a perfect match between game changing glucose sensing hardware and industry leading data management software," says Anders Sonesson, CEO at Diasend.
Starting today, it is possible for patients using Abbott's FreeStyle Libre system in countries where the LibreLink app is available to import information directly into diasend® – the industry leading solution for diabetes data management. All that is needed is a compatible Android smartphone** equipped with the LibreLink app, a connected FreeStyle Libre sensor and the one-time effort of connecting the two systems.
The current glucose level is read by simply scanning the sensor with the back of the Android phone. Data is then automatically populated into the patient's diasend® account through the cloud, which can be easily linked with one's health care provider – meaning that information is passively mirrored into the linked clinic account.
"At Abbott, we are committed to helping people achieve their best health so we strive to give our customers access to the best possible products and services to help them better manage their diabetes," says Eric Davis, director of New Product Innovation, diabetes care, Abbott. "Our collaboration with Diasend is one more step in that direction and we are excited to bring our customers even closer together with their physicians."
With diasend®, patients will also be able to view their FreeStyle Libre data combined with information from any other diasend® compatible device, such as insulin pumps, blood glucose meters and/or activity trackers. With everything securely stored and easily accessible in one place for both patients and health care providers.
"We are very excited about the collaboration and the valuable addition that FreeStyle Libre is to our line-up of cloud connections, especially as we note a growing appreciation amongst clinics for passively acquired data. This will make diasend® even more functional within both our existing type 1 offering and our upcoming venture into type 2 diabetes," says Anders Sonesson, CEO at Diasend AB.
Diasend has spent the last decade simplifying life for people with diabetes and healthcare providers by optimizing diabetes data management. The diasend® system enables users to easily upload, analyze and store data from more than 140 different glucose meters, insulin pumps, CGM systems (continuous glucose monitoring) and leading activity trackers. All completely free for patients. The company's constantly evolving solution supports cloud-to-cloud integration as well as mobile uploads via wireless technologies such as BLE and NFC.
All combined, this makes diasend® the most universal data aggregation solution in the world – and with more than 400,000 unique active patients during the last 12 months the system now boasts over 1 million unique device uploads. 2016 marks the company's 11th year in business, now proudly supporting 3,000 clinics in 27 countries. Diasend is FDA and HIPAA compliant and ISO 13485 certified. Diasend has offices in USA, United Kingdom and Sweden. www.diasend.com
For more information, please contact:
Global Marketing Director, Diasend
+46 701 46 10 10
For more information about LibreLink:
In Sweden: Cia Zingmark, +46 709 160 670
Globally: Fiona Lloyd, +44 7780 955 718
Developed by AirStrip Technologies, the LibreLink app is the only app approved and certified for use with the FreeStyle Libre sensor***. For more information about Abbott's FreeStyle Libre System, please go to www.FreeStyleLibre.com.
* LibreLink is a mobile application, developed and provided by AirStrip. Use of LibreLink requires registration with LibreView, a service provided by Abbott and Newyu, Inc. FreeStyle Libre readers and sensors are provided by Abbott. Data charges may apply when downloading the LibreLink app.
** The LibreLink app is compatible with phones that support NFC and run Android 4.0 or higher.
*** The LibreLink app and the FreeStyle Libre reader have similar but not identical features. A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycemia or impending hypoglycemia is reported by the LibreLink app or when symptoms do not match the LibreLink app readings.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diasend-collaborates-with-abbott-to-simplify-diabetes-data-management-300282333.html